Clinical Trials
3 trialsNCT05768139 2026-05-22
PIKALO-1
Eli Lilly and Company
Phase 1/2 Recruiting
NCT03300557 2025-08-29
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01965080 2013-10-18
Exemestane in Advanced and Recurrent Endometrial Carcinoma
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 2 Completed